This website is intended for healthcare professionals only

Luigi Di Biase, AFS 2022: Peri and post procedural anticoagulation with LAA closure devices

5 mins
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Feb 24th 2022

The advantages and challenges of peri and post procedural anticoagulation with LAA closure devices were discussed by Prof. Luigi Di Biase in a short interview with touchCARDIO, at the annual AF Symposium 2022.

The abstract entitled ‘Peri and Post Procedural Anticoagulation with LAA Closure Devices – An Evolving Story’ was presented at the annual AF Symposium, January 13-15, 2022.

Questions:

  1. What are the advantages and disadvantages of left atrial appendage (LAA) closure as opposed to the use of direct-acting oral anticoagulants in high-risk patients with atrial fibrillation? (0:15)
  2. Why is peri-and post-procedural anticoagulants needed with LAA closure devices? (1:19)
  3. What are the challenges of peri-and post-procedural anticoagulants with LAA closure devices? (2:21)
  4. What have we learned about optimal peri- and post-procedural anticoagulation in this clinical scenario? (3:18)
  5. What questions remain unanswered and what further research is needed? (4:28)

Disclosures: Luigi Di Biase has nothing to disclose in relation to this video interview

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.

Filmed as a highlight of AFS 2022. 

Click here for more content from Prof. Luigi Di Biase.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup